Corrigendum to “Nitrosamines crisis in pharmaceuticals - Insights on toxicological implications, root causes and risk assessment: A systematic review” [J. Pharm. Anal. 14 (2024) 100919]

doi: 10.1016/j.jpha.2024.101033

• Hemanth P. R. Vikram^a,b , 
• Tegginamath Pramod Kumar^c , 
• Gunjan Kumar^b , 
• Narasimha M. Beeraka^d,e,f , 
• Rajashree Deka^g , 
• Sheik Mohammed Suhail^h , 
• Sandeep Jatⁱ , 
• Namitha Bannimath^j , 
• Gayatiri Padmanabhan^a , 
• Ravandur S. Chandan^a , 
• Pramod Kumarⁱ , 
• Bannimath Gurupadayya^{a ,  ,} 

• a. Department of Pharmaceutical Chemistry, JSS College of Pharmacy Mysuru, JSS Academy of Higher Education and Research (JSSAHER), Mysuru, 570015, India;

• b. Xenone Healthcare Pvt. Ltd., New Delhi, 110076, India;

• c. Department of Pharmaceutics, JSS College of Pharmacy Mysuru, JSS Academy of Higher Education and Research (JSSAHER), Mysuru, 570015, India;

• d. Department of Human Anatomy, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119991, Russian Federation;

• e. Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Ananthapuramu, 515721, India;

• f. Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA;

• g. Animal Physiology and Biochemistry Laboratory, Department of Zoology, Gauhati University, Guwahati, 781014, India;

• h. Department of Pharmacology, JSS College of Pharmacy Mysuru, JSS Academy of Higher Education and Research (JSSAHER), Mysuru, 570015, India;

• i. Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Changsari, 781101, India;

• j. Department of Pharmacology, University of Galway, Galway, H91 TK33, Ireland